- collapse Phase III Randomised, Double Blind, Placebo Controlled Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed BRCA Mutated Ovarian Cancer Patients with a Complete or Partial Response Following Platinum based Chemotherapy
- collapse TIGRIS: Long-Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease in post myocardial infarction patients
- collapse A study to evaluate the use of mobile-phone based patient support in patients diagnosed with Myocardial Infarction - SUPPORT
- collapse A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients with Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants.
- collapse A Randomized, Double-Blind, Two-Period Crossover Study to Assess Safety, Tolerability, and Pharmacokinetics Following Repeated Doses of AZD6140 (400 mg od) and Digoxin (0.25 mg od) in Healthy Male and Female Volunteers
- collapse ProAcor: Prospective Structured Care In Acute Coronary Syndrome Registry
- collapse A multicenter, single arm, open label, Phase IV study to evaluate safety and to describe the incidence of major cardiovascular events of ticagrelor in Chinese patients with acute coronary syndrome
- collapse An Efficacy and 2-Year Safety Study of Open-label Rosuvastatin in Children and Adolescents (Aged From 6 to Less Than 18 Years) With Familial Hypercholesterolaemia
- collapse Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)
- collapse A Randomised, Double-blind, Placebo-controlled Phase IIa Study to Assess the Pharmacodynamics, Safety, and Pharmacokinetics of AZD4901 When Given in Multiple Doses to Females with Polycystic Ovary Syndrome
